metformin has been researched along with Epidermolysis Bullosa Acquisita in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Epidermolysis Bullosa Acquisita: Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IMMUNOGLOBULIN G deposited at the dermo-epidermal junction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schilf, P | 1 |
| Schmitz, M | 1 |
| Derenda-Hell, A | 1 |
| Thieme, M | 1 |
| Bremer, T | 1 |
| Vaeth, M | 1 |
| Zillikens, D | 1 |
| Sadik, CD | 1 |
1 other study available for metformin and Epidermolysis Bullosa Acquisita
| Article | Year |
|---|---|
Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
Topics: Animals; Autoantibodies; Deoxyglucose; Disease Models, Animal; Epidermolysis Bullosa Acquisita; Gluc | 2021 |